NCT00395681View on ClinicalTrials.gov

Population PK/PD of Propofol in the Morbidly Obese Patient

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Morbid Obesity
Interventions
DRUG

Diprivan

Propofol 200 mg versus 350 mg

Trial Locations (1)

Unknown

st. Antonius hospital, Nieuwegein

All Listed Sponsors
lead

St. Antonius Hospital

OTHER

NCT00395681 - Population PK/PD of Propofol in the Morbidly Obese Patient | Biotech Hunter | Biotech Hunter